InvestorsHub Logo
Followers 572
Posts 9510
Boards Moderated 1
Alias Born 09/03/2004

Re: None

Thursday, 10/19/2017 9:28:28 AM

Thursday, October 19, 2017 9:28:28 AM

Post# of 49606
ONCS shows positive early clinical results combination with Keytruda for non responsive melanoma patients. Not much market response.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.